Kate Porter

Kate Porter has extensive experience in the field of pre-clinical and clinical research and development, with a focus on immunology, small-molecule oncology, antiviral, and antibacterial spaces. Kate has held various leadership positions in reputable organizations such as Crux Biolabs, Noxopharm, and BIOTA. Kate's educational background includes a PhD in Microbiology and a Bachelor of Biomedical Science. Additionally, Kate has experience in mentoring and facilitating science education programs.